Search for: "Grant v. Janssen Research "
Results 1 - 20
of 34
Sorted by Relevance
|
Sort by Date
5 Sep 2008, 8:28 am
Prosthetics Research Assocs., Inc. v. [read post]
27 Sep 2009, 2:30 pm
In Re '318 Patent Infringment Litigation: Janssen Pharmaceutica v. [read post]
23 Oct 2009, 4:12 pm
In In re ‘318 Patent Infringement Litigation (Janssen Pharmaceutica N.V. v. [read post]
28 Apr 2019, 7:45 am
In 1977 Edmund Kitch said that the grant of a patent could also have the purpose of encouraging further research on the patented subject matter, giving an analogy to a mining claim of staking out an area for further research. [read post]
12 Aug 2014, 8:00 pm
Janssen Biotech, Inc., No. 2013-1338, 1346 (Fed. [read post]
7 Nov 2008, 3:42 am
Sandoz, Inc (Patent Docs) (PATracer) Boniva (Ibandronic acid) – US: Hoffman La Roche files third patent infringement lawsuit against Orchid over generic Boniva (GenericsWeb) Carbatrol (Carbamazepine) – US: Federal Judge grants summary judgment of noninfringement to Corepharma in Carbatrol patent dispute with Shire Laboratories (Law360) Effexor (Venlafaxine) – US: Wyeth settles with fourth drug company, Anchen Pharmaceuticals, over generic Effexor (Law360)… [read post]
11 Jan 2011, 11:07 pm
Supreme Court to take on patent settlement agreements: Louisiana Wholesale Drug Co et al v Bayer et al (FDA Law Blog) US: BIO joins 170 business, research institutions and organisations to urge caution in Microsoft v i4i case (PatentlyBIOtech) US: Galderma wins important victory in fight against Leo’s psoriasis patent covering vitamin D, corticosteroid composition for ‘dermal use’ (Reexamination Alert) US: Déjà vu! [read post]
2 Nov 2011, 2:00 am
Research & Diagnostic Systems (Pharma Patents) US: Roundup Ready® Soybeans: Patent exhaustion in self-replicating biotechnologies (IP Osgoode) US: FDA continues efforts to expand power over intrastate commerce (FDA Law Blog) US: Defendants’ persistence in pursuing “baseless inequitable conduct claim” justified award of attorneys’ fees to plaintiff: Pfizer et. al v. [read post]
6 Dec 2021, 6:24 am
Phase 2/3 clinical trials began in February 2021 for Pfizer/BioNTech and Janssen and included pregnant people. [read post]
10 Feb 2010, 4:47 pm
(Patent Docs) Pataday (Olopatadine hydrochloride ophthalmic solution) – US: Patent infringement complaint filed in S D Indiana following a Paragraph IV certification: Alcon Research, Ltd. et al. v. [read post]
4 May 2017, 1:00 am
Relevant Judicial Practice Boehringer Ingelheim Pharma GmbH & Co KG v. [read post]
18 Nov 2016, 12:44 am
The judge held that the “undue burden” concept in English law (particularly as outlined by Arnold J in Eli Lilly v Janssen in 2014) was not particularly helpful under Australian law. [read post]
22 Oct 2021, 11:36 am
They argued that Johnson & Johnson/Janssen used cells ultimately derived from an aborted fetus to produce its vaccine, as did Moderna and Pfizer/BioNTech in researching their vaccines. [read post]
22 Oct 2021, 11:36 am
They argued that Johnson & Johnson/Janssen used cells ultimately derived from an aborted fetus to produce its vaccine, as did Moderna and Pfizer/BioNTech in researching their vaccines. [read post]
15 Jul 2009, 5:15 am
IPAB rejects Novartis’ patent application for Glivec (Intellectual Property Watch) Lescol (Fluvastatin) – Netherlands: No interim relief pending appeal against invalidity, rules District Court of The Hague: Novartis v Mylan and Actavis (PatLit) Levaquin (Levoflaxacin) – Canada: FCA holds generics raising allegations similar to those of previous generics allowed their day in court: Apotex v Janssen-Ortho (Global IP Watch) Lexapro (Escitalopram)… [read post]
21 Feb 2021, 4:07 pm
Mr Justice Tony O’Connor granted an ex-parte application by Mr Ganley’s lawyers permitting legal papers to be served outside the jurisdiction on CNN. [read post]
24 Apr 2013, 8:31 am
Food & Drug Law Institute Annual Conference Top 20 Cases in Food & Drug Law in 2012 and Cases to Watch in 2013 Bill Janssen, Charleston School of Law: Weddle v. [read post]
15 Dec 2010, 2:17 am
Becton, Dickinson & Co (Intellectual Property Law Blog) US: Regents of the University of California pursue new patent re-examination in District Court (Patents Post Grant Blog) US: Microsoft v i4i, the burden of proof and the pharma sector (PatLit) US: IRS issues notice to implement annual fee on brand drugs (FDA Law Blog) US: Bright ‘orphan’ ideas blossom (FDA Law Blog) US: Amicus briefs in AMP v USPTO (Patent Docs) (Patent Docs) (Patent Docs) US:… [read post]
5 Sep 2013, 12:24 pm
Ortho-McNeil-Janssen Pharmaceuticals, Inc., 808 F. [read post]
25 Nov 2009, 3:00 am
Ltd v Underworks Ptd. [read post]
